North America HIV Drugs Market Report by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors—CCR5 Co-Receptor Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Country 2025-2033

North America HIV Drugs Market Report by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors—CCR5 Co-Receptor Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Country 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1762

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global HIV Drugs Market
    5.1    Market Performance
    5.2    Market Breakup by Drug Class
    5.3    Market Breakup by Distribution Channel 
    5.4    Market Breakup by Region 
    5.5    Market Forecast 
6   North America HIV Drugs Market
    6.1    Market Performance
    6.2    Impact of COVID-19
    6.3    Market Forecast 
7   North America HIV Drugs Market: Breakup by Drug Class 
    7.1    Nucleoside Reverse Transcriptase Inhibitors
    7.2    Multi-Class Combination Products
    7.3    Protease Inhibitors
    7.4    HIV Integrase Strand Transfer Inhibitors
    7.5    Non-Nucleoside Reverse Transcriptase Inhibitors
    7.6    Entry Inhibitors—CCR5 Co-Receptor Antagonist
    7.7    Others
8   North America HIV Drugs Market: Breakup by Distribution Channel 
    8.1    Hospital Pharmacies
    8.2    Retail Pharmacies
    8.3    Online Pharmacies
    8.4    Others
9   North America HIV Drugs Market: Breakup by Country 
    9.1   United States
     9.1.1    Historical Market Trends
     9.1.2    Market Breakup by Drug Class
     9.1.3    Market Breakup by Distribution Channel
     9.1.4    Market Forecast
    9.2   Canada
     9.2.1    Historical Market Trends
     9.2.2    Market Breakup by Drug Class
     9.2.3    Market Breakup by Distribution Channel
     9.2.4    Market Forecast
10  SWOT Analysis 
    10.1    Overview 
    10.2    Strengths
    10.3    Weaknesses 
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis 
    11.1    Overview
    11.2    Research and Development
    11.3    Raw Material Procurement
    11.4    Manufacturing
    11.5    Marketing
    11.6    Distribution
    11.7    End-Use
12  Porter’s Five Forces Analysis 
    12.1     Overview
    12.2     Bargaining Power of Buyers
    12.3     Bargaining Power of Suppliers
    12.4     Degree of Rivalry
    12.5     Threat of New Entrants
    12.6     Threat of Substitutes
13  Price Analysis 
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players

List of Figures

​Figure 1: North America: HIV Drugs Market: Major Drivers and Challenges
Figure 2: Global: HIV Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: HIV Drugs Market: Breakup by Drug Class (in %), 2024
Figure 4: Global: HIV Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 5: Global: HIV Drugs Market: Breakup by Region (in %), 2024
Figure 6: Global: HIV Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: North America: HIV Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 8: North America: HIV Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: North America: HIV Drugs Market: Breakup by Drug Class (in %), 2024
Figure 10: North America: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: North America: HIV Drugs (Nucleoside Reverse Transcriptase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: North America: HIV Drugs (Multi-Class Combination Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: North America: HIV Drugs (Multi-Class Combination Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: North America: HIV Drugs (Protease Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: North America: HIV Drugs (Protease Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: North America: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: North America: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: North America: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: North America: HIV Drugs (Non-Nucleoside Reverse Transcriptase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: North America: HIV Drugs (Entry Inhibitors—CCR5 Co-Receptor Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: North America: HIV Drugs (Entry Inhibitors—CCR5 Co-Receptor Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: North America: HIV Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: North America: HIV Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: North America: HIV Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 25: North America: HIV Drugs Market: Sales through Hospital Pharmacies (in Million USD), 2019 & 2024
Figure 26: North America: HIV Drugs Market Forecast: Sales through Hospital Pharmacies (in Million USD), 2025-2033
Figure 27: North America: HIV Drugs Market: Sales through Retail Pharmacies (in Million USD), 2019 & 2024
Figure 28: North America: HIV Drugs Market Forecast: Sales through Retail Pharmacies (in Million USD), 2025-2033
Figure 29: North America: HIV Drugs Market: Sales through Online Pharmacies (in Million USD), 2019 & 2024
Figure 30: North America: HIV Drugs Market Forecast: Sales through Online Pharmacies (in Million USD), 2025-2033
Figure 31: North America: HIV Drugs Market: Sales through Other Distribution Channels (in Million USD), 2019 & 2024
Figure 32: North America: HIV Drugs Market Forecast: Sales through Other Distribution Channels (in Million USD), 2025-2033
Figure 33: North America: HIV Drugs Market: Breakup by Country (in %), 2024
Figure 34: United States: HIV Drugs Market: Sales Value (in Million USD), 2019-2024
Figure 35: United States: HIV Drugs Market: Breakup by Drug Class (in %), 2024
Figure 36: United States: HIV Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 37: United States: HIV Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Canada: HIV Drugs Market: Sales Value (in Million USD), 2019-2024
Figure 39: Canada: HIV Drugs Market: Breakup by Drug Class (in %), 2024
Figure 40: Canada: HIV Drugs Market: Breakup by Distribution Channel (in %), 2024
Figure 41: Canada: HIV Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: North America: HIV Drugs Industry: SWOT Analysis
Figure 43: North America: HIV Drugs Industry: Value Chain Analysis
Figure 44: North America: HIV Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: North America: HIV Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: North America: HIV Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: North America: HIV Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 4: North America: HIV Drugs Market Forecast: Breakup by Country (in Million USD), 2025-2033
Table 5: North America: HIV Drugs Market: Competitive Structure
Table 6: North America: HIV Drugs Market: Key Players

North America HIV Drugs Market Report by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Multi-Class Combination Products, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors—CCR5 Co-Receptor Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Country 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials